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Patent ductus arteriosus stenting for palliation of suprasystemic pul-
monary arterial hypertension: a novel interventional instrument to
improve outcome
Younes Boudjemline, Sophie Malekzadeh-Milani, Marilyne Levy, Damien
Bonnet
Hôpital Necker Enfants Malades, Cardiologie pédiatrique, Paris, France
Aim: Side to side surgical Potts shunt connecting descending thoracic aorta
to the left pulmonary artery have been tried in the past for patients with symp-
tomatic severe and refractory idiopathic pulmonary arterial hypertension
(IPAH) with right ventricular failure and syncope. The promising results from
this surgical technique inspired us to try interventional methods in opening
and stenting residual patent ductus arteriosus (PDA) for effective post tri-
cuspid decompression of the pulmonary circuit in patients with chronic supra-
systemic PAH who failed multiple medical therapies.
Methods and results: We look in our database for patients with supra-
systemic PAH who underwent PDA stenting to decrease PA pressure. Three
patients were found.
All three had successful PDA stenting allowing for equalization of aortic and
pulmonary systolic pressure. The saturation in lower limbs decreased as a result.
All patients had improvement of their clinical status following the procedure.
Conclusions: The promising results from these cases compelled us to
change the approach and protocol for management of patients with suprasys-
temic PAH. We now do a detailed cardiac catheterization in all patients with
suprasystemic PAH to look for a PDA. Even tiny it can be opened by stent
insertion to equalize aortic and pulmonary pressure and improve RV function.
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Tetralogy of Fallot associated with coarctation of the aorta: report of
four cases and literature review
Elodie Perdreau (1), Lucile Houyel (2), Régine Roussin (2), Jérôme Petit (2),
Alban-Elouen Baruteau (2)
(1) CHU Haut-Lévêque, Cardiologie Pédiatrique, Pessac, France –
(2) Centre Chirurgical Marie Lannelongue-M3C, Chirurgie des Cardio-
pathies Congénitales, Le Plessis-Robinson, France
Introduction: Tetralogy of Fallot and coarctation of the aorta is an excep-
tional association. We report here four cases of this rare combination. 
Observations: From 1974 to 2013, 4 infants were referred for tetralogy of
Fallot with or without pulmonary atresia associated with a right aortic arch
and aortic coarctation. In all cases, the coarctation was abnormally situated
between the right common carotid and the right subclavian arteries. Two cases
had an abnormal left subclavian artery. One child had a DiGeorge syndrome.
All underwent staged surgical repairs of the left and right-sided obstructions.
Discussion: Association of tetralogy of Fallot and aortic coarctation is highly
unusual. It is often associated with a right aortic arch and aortic arch vessels anom-
alies. The diagnosis of the coarctation of the aorta can be challenging as the clin-
ical signs are paradoxical to a tetralogy of Fallot and carries important clinical and
surgical implications. A review of literature shows two types of coarctation in this
context: coarctation with left-sided aorta, located as usual at the level of the
isthmus, and coarctation with right-sided aorta located similar to aortic arch inter-
ruption type B associated with anomalies of arch vessels branching. In this latter
group, coarctation should be considered a complex anomaly of aortic arches in the
setting of a conotruncal defect (tetralogy of Fallot) due to an abnormal migration
of cardiac neural crest cells, rather than a left heart obstruction. 
Conclusion: Looking for right aortic arch, aortic coarctation and aortic
arch vessels anomalies is crucial in patients with a tetralogy of Fallot, even if
this association is reported to be very rare.
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Transcatheter ASD occlusion: a comparison between the occlutech
figulla occluder and the amplatzer septal occluder.
François Godart (1), Ali Houeijeh (1), Morgan Recher (1), Marie-Paule
Guillaume (1), Anne Sophie Polge (2), Marjorie Richardson (2)
(1) CHRU Lille, Hôpital Cardiologique, Service des Maladies Cardiovas-
culaires Infantiles et Congénitales, Lille, France – (2) CHRU Lille,
Hôpital Cardiologique, Service des Explorations Fonctionnelles Cardio-
vasculaires, Lille, France
We report here one centre experience in transcatheter closure of ASD using
both the Figulla ASD occluder (Occlutech) and the Amplatzer septal occluder
(ASO)(St Jude Medical). A comparative study is performed during a same
period of time. 
From September 2009 to December 2012, 131 consecutive patients under-
went percutaneous ASD occlusion and choice of the device was determined
after balloon sizing. During this time period, 31 patients underwent ASD
occlusion with the Figulla device: 17 females, 14 males, with a mean age of
36.8±23 years, a mean device size of 20.2±5.6 mm. The fluoroscopic time was
4.5±1.7 minutes, radiation dose 15.3±13 Gycm2. Device implantation suc-
ceeded in all but 2: one because of deficient posterior rim, and a second one
(boy aged 4 yrs) due to complete AV block that resolved after percutaneous
device extraction. During follow-up, no shunt was observed in all but one. 
During the same period of time, 100 patients had ASD occlusion with
ASO: 59 females, 41 males, with a mean age of 32.8±25.7 years, a mean
device size of 20.4±7.1 mm. The fluoroscopic time was 6.4±9.5 minutes,
radiation dose 20.0±23.8 Gycm2. Implantation succeeded in all but 2 due to
deficient rim. Another patient had device embolization in the aorta noticed in
the following hours after implantation. This device was retrieved by catheter-
ization and this patient underwent 2 months later successful transcatheter ASD
occlusion with another larger ASO. During follow-up, 85 pts had no residual
shunt, 9 pts trivial shunt, and 3 others had persistent interatrial small shunt due
to adjacent ASD close the device with no RV overload.
Transcatheter closure of ASD with the Occlutech Figulla device is feasible
and safe with no learning curve since the implantation technique is similar to
that of the ASO. Results of the Occlutech Figulla devices compare favourably
with those of the ASO. However additional long-term results including more
patients are mandatory.
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A method for accurate, non-destructive diagnosis of congenital heart
defects from heart specimens
Jean-Marc Schleich (1), Tariq Abdulla (2), Lucile Houyel (3), Jean-
François Paul (3), Ron Summers (2), Jean-Louis Dillenseger (4)
(1) CHU Rennes – Hôpital Pontchailloux, Cardiologie et maladies vascu-
laires, Rennes, France – (2) Research School of Systems Engineering,
Loughborough University, Loughborough, Royaume-Uni – (3) Hôpital
Marie-Lannelongue, Le Plessis Robinson, France – (4) Université de
Rennes 1, LTSI / Unité INSERM U1099, Rennes, France
The accurate analysis of congenital heart defect (CHD) specimens is diffi-
cult and up to now required the opening of the heart. The objective of the
study is to define a non-destructive method that allows for the precise analysis
of each specimen and its different cardiac components in order to improve
classification of the defect and thus provide an indication of underpinning
causal mechanisms. For this, it is necessary to extract the dimensional charac-
teristics and spatial relations of these components using an indexing method.
The first phase of analysis is to construct images from the mean values of 3D
models implemented from the aggregated CT scan acquisitions of normal
heart and hearts with Tetralogy of Fallot (conotruncal defects).
Methods: The volumes of ex-vivo hearts were acquired by a high resolu-
tion CT scan (0.15x0.15 mm2 pixel size, 0.1 mm interslice spacing). A new
3D manipulation tool was developed using the ImageJ package to define ana-
tomical landmarks interactively within the heart volumes. These landmarks
can be picked, adjusted, validated and corrected on either the 3D perpendic-
ular slices or on a 3D surface visualization of the heart.
Results: From the landmarks obtained, the geometrical characteristcs of
the following heart components are defined: entrance point and orientation of
the coronary arteries, position, orientation and surface of pulmonary, aortic,
tricuspid and mitral annulus, and ventricular septal defect. The relative dis-
tances and angles of these elements can be compared to the normal heart and
between each specimen within a group of CHD specimens.
Conclusions: Without opening the heart, the method described allows
accurate analysis of specimens and the definition of 3D relations between the
heart components. All results will be shared with the anatomo-pathologist
community. Furthermore, from the average model, it could be possible to gen-
erate some embryological hypotheses about the morphogenesis of particular
CHD, like conotruncal defects.
314
Long term follow-up after heart transplantation in very young chil-
dren 
Magali Veyrier, Corinne Ducreux, Roland Henaine, François Sassolas,
Jean Ninet, André Bozio, Sylvie Di Fillipo
Hôpital Cardiovasculaire, Cardiologie Pédiatrique et Congénitale, Lyon,
France
The aim of this study was to review long-term follow-up of heart trans-
planted small children to assess prognosis and outcomes.
Material and methods: Patients who underwent orthotopic heart trans-
plantation (OHT) within the first 3 years of life were included in the study.
Demographics, clinical data, events, outcomes and survival were assessed. 
Results: Among 96 paediatric heart transplantations performed in a French
single-centre, 25 were included in the study (10 males, 15 females). Among
them, 10 (40%) were on VAD support at the time of OHT. Age at OHT was
1.5±0.9years (median 1.2). Underlying cardiac disease was congenital in 4
(16%) or idiopathic cardiomyopathy in 21 (84%). Post-transplant follow-up
was 7.1±7years (range 1day to 22.7) and was > 10year in 7 cases (28%).
Three patients died at 1st day, 2nd year and 4th year post-transplant. Mean age
of survivors at the time of the study was 9.1±7.3years (range 1.5 to 23.6). One
acute rejection episode occurred in 2 patients, at 1st month and one at 11st
year. One post-transplant lympho-proliferative disease occurred at 14th year
post-transplant and was successfully cured. Graft coronary disease occurred in
2 cases (8%), who underwent 2nd-heart and kidney transplantation at 16th and
22th year after first transplant. All others were free from coronary disease with
normal graft function. End-stage renal failure occurred in the 2 re-transplanted
cases. Severe renal dysfunction was present in 3 cases (no dialysis), moderate
in 3 cases, and 17 had normal renal function. Linear growth was normal in all
patients, except the 2 cases with end-stage renal failure, despite maintenance
low dose steroids in 80% of the survivors. All are in NYHA class I, except the
2 re-transplanted cases who were in class IV at the time of 2nd transplant.
Patient survival was 96% at 1-year, 90.7% at 3-year and 83% at 10-year post-
transplant. Graft survival was respectively 96%, 90.7%, 83% and 66% at 1, 3,
10 and 16-year follow-up.
Conclusion: Long-term survival of very young heart transplant recipient is
acceptable, with low incidence of graft coronary disease and optimal func-
tional status and growth.
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Novel method of surgical preparation for transcatheter completion of
fontan circulation: creation of an extracardiac pathway
Sebastien Gerelli (1), Mathieu Van Steenberghe (2), Yann Boegli (3),
Sophie Malekzadeh-Milani (2), Younes Boudjemline (2)
(1) CH Strasbourg, Strasbourg, France – (2) Hôpital Necker Enfants
Malades, Cardiologie Pédiatrique, Paris, France – (3) CHU Vaudois,
Lausanne, France
Objectives: We report creation of a novel surgical preparation for trans-
catheter completion of extracardiac Fontan circulation.
Methods: Nine lambs underwent surgical preparation; inferior vena cava
(IVC) was cut with right atrium (RA) rim and anastomosed end-to-end with
the inferior end of a Gore-tex conduit. A nitinol ring was placed around the
IVC near the anastomosis. The SVC was cut and connected end-to-end with
the RA auricle. Upper segment of Gore-tex tube was opened and connected to
RA to allow free flow of IVC blood. The superior end was closed using PTFE
membrane and a stented segment harvested from Contegra conduit was inter-
posed between the superior end and the SVC for smooth transition. Fontan
completion (opening of the SVC connection and closure of the fenestration)
was attempted at 1-3 months following surgery. Animals were sacrificed just
after (n=7) and 3 months after completion (n=2). 
Results: All lambs were successfully preconditioned with one postopera-
tive death due to SVC-RA occlusion, one elective sacrifice after 2-months to
assess pathway integrity and seven successful completions. Autopsy findings
showed widely patent IVC and SVC and covered stents well deployed to
completely occlude fenestration. Figure – 3D views / landmarks represented by yellow spheres
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Conclusions: A new method of surgical preparation and its subsequent
transcatheter completion of extracardiac Fontan is created. This surgical prep-
aration opens new frontiers for transcatheter and hybrid techniques for extra-
cardiac Fontan completion. 
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Interest of levosimendan for children who are on the waiting list for
heart transplantation
Pierre-Emmanuel Séguéla, Jean-Baptiste Mouton, Nadir Tafer, Jean-
Benoit Thambo, Philippe Mauriat
CHU Bordeaux-Hôpital Haut-Lévèque, Cardiologie Pédiatrique et Congé-
nitale, Pessac, France
Introduction: Heart transplantation (HTx) remains the gold standard
therapy for pediatric end-stage heart failure. However, the expectation of a
transplant may be long and a mechanical support is sometimes required
despite the use of conventional inotropic drugs. Owing to its prolonged action,
levosimendan was proved to be efficient for the treatment of postoperative
low cardiac output syndrome in children. 
Aims: To study the effects of levosimendan in children who are waiting
for HTx.
Patients and methods: Single-center retrospective study. Pediatric patients,
under 18 years, in end-stage heart failure and with criteria for mechanical sup-
port, were included. All the patients were on the waiting list for HTx. Each
patient received at least one 24 hours infusion of levosimendan until he had
either a HTx or a mechanical support. Clinical, biological and echocardiographic
data were analyzed according to the infusions of levosimendan. 
Results: A total of 6 patients were included over a period of 24 months. The
median age was 2 years (2 months-15 years). A total of 82 infusions were per-
formed. Levosimendan had a positive effect on enteral feeding. The median
BNP level decreased significantly between day 0 and day 2 (2443 ng/L [1458-
3819] versus 1358 ng/L [1025-2534], p=0.003). While only a trend was noted
in the improvement of the LVEF (p=0.054 by the Simpson’s method and
p=0.068 by the Teicholz method), the subaortic velocity time integral was signifi-
cantly improved between day 0 and day 8 (12.8 cm/s [10-14.5] vs 15.3 cm/s
[14.3-16.9], p=0.041). Even if the efficacy of levosimendan seemed to progres-
sively decrease over the time, the use of this drug allowed an average « life free
from mechanical support » of 177 days. During this study, no adverse events
have been reported, or attributed, to the use of levosimendan. 
Conclusion: Levosimendan improves hemodynamics of children in end-
stage heart failure, allowing several months of life without any mechanical
support. Thus, levosimendan has to be used, in addition of usual inotropic
drugs, in this context. Several clinical and biological criteria may help to
determine the best timing for infusions.
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Malposition of the great arteries: a new 3D echocardiographic
approach
Khaled Hadeed, Sébastien Hascoet, Marianne Peyre, Romain Amadieu,
Yves Dulac, Philippe Acar
CHU Toulouse, Hôpital des enfants, Cardiologie pédiatrique, Toulouse,
France 
Purpose: Geometric profile of the left and right outlets as well as position
and size of the ventricular septal defects (VSD) determine the surgical
approach of malposition of the great vessels. 
Aim: To determine the ability of the 3D echocardiography (3DE) to depict
the outlet chambers in normal and pathologic situations.
Methods: Twenty patients were prospectively enrolled (10 had normal heart,
5 tetralogy of Fallot (TOF), 3 double outlet right ventricle (DORV), 2 double
discordance (DD) with VSD). The median age was 3.6 years (range 2 months-
13 years). All underwent transthoracic 3DE (Philips, ie 33, X5-1 and X7-2). Full
volume and Live 3D acquisition were performed. Off-line analysis was per-
formed using a dedicated system (Qlab version 9). An asymmetry index of the
VSD was calculated by the maximal 3D diameter divided by the minimal 3D
diameter. A cut-off of 1.25 was set to distinguish ovale and circular shape. 
Results: Mitro-aortic continuity was observed in all controls and patients
with TOF. Mitro-aortic distance was measured in patients with DORV
(36mm/m²). Septo-aortic and septo-pulmonary continuity was observed
respectively in control and DD with VSD. Distance between tricuspid and pul-
monary valve was (25.7mm/m²) in control, (54.4mm/m²) in TOF, (58.9mm/m²) in
DORV, and (17.5 mm/m²) in DD. VSD was in sub-aortic position in TOF and
in 3 DORV; in sub-pulmonary position in 2 DD. Mean size of the VSD was
13,8 mm (27.3mm/m²). Shape of the VSD was circular in all but one DD with
small oval VSD; subvalvular insertion on VSD crest was observed in the same
patient responsible of sub-pulmonary stenosis. 
Conclusions: 3DE is able to describe the outlet chambers and VSD posi-
tion and geometry. Thus could held do determine the better surgical strategy
to correct patient with malposition of the great vessels.
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Factors of negativity of electrophysiological study in children and
teenagers complaining of tachycardia. 
Béatrice Brembilla-Perrot (1), Jean-Marc Sellal (1), Jérôme Schwartz (1),
Arnaud Olivier (1), Marie Odile Marc (1), Joseph Rizk (1), Marie Paule
Houppe Nousse (1), Samira Taïhi (2), Renaud Piquemal (3), Boubekeur Taleb
(4), Carole Nrecaj-Jager (5), François Marçon (5), Anne Moulin-Zinsch (5)
(1) CHU Brabois, Cardiologie, Vandoeuvre Les Nancy, France –
(2) CHR, Cardiologie, Bar Le Duc, France – (3) Cardiologie, Thionville,
France – (4) CHR, Cardiologie, Sarreguemines, France – (5) CHU Bra-
bois, Cardiologie pédiatrique, Vandoeuvre Les Nancy, France
When noninvasive studies remain negative, the diagnosis of unexplained
tachycardia in the youth remains a dilemma. Invasive electrophysiological
study (EPS) requires generally anesthesia and hospitalization in young chil-
dren. The purpose of the study was to determine the factors of negativity of
transesophageal EPS in children and teenagers complaining of tachycardia.
Methods: 214 children, aged from 6 to 19 years, mean 15±3, were studied
for no documented tachycardia and a normal ECG in sinus rhythm. Trans-
esophageal EPS was performed in out-patient clinic without sedation but in
presence of parents; EPS consisted of atrial pacing and atrial stimulation with
1 and 2 extrastimuli in control state and after isoproterenol. Long-term Holter
monitoring was systematic in patients with negative EPS. 
Results: Supraventricular tachycardia (SVT) was induced in 131 patients
(group I) and EPS remained negative in 83 patients (group II). Age of both
groups did not differ significantly despite a tendency for lower age in group I
(14±3) than in group II (15±3) (p 0.075). Female gender did not differ signif-
icantly in group I (48%) and II (59%)(0.11). Feeling of dizziness or syncope
with tachycardia was more frequent in group II (46%) than in group I
(13%)(p<0.0001). Feeling of chest pain with tachycardia was more frequent in
group II (22%) than in group I (0.8%)(p<0.0001). History of familial SVT didFigure – BNP level evolution after levosimendan infusion
© Elsevier Masson SAS. All rights reserved.
 
108 Archives of Cardiovascular Diseases Supplements (2014) 6, 95-109
not differ significantly in group I (5%) and II (22%)(0.23). Long-term Holter
monitoring confirmed the absence of organic supraventricular tachycardias in
all patients of group II and indicated only a sinus tachycardia.
Conclusions: Neither the age and the gender can predict the nature of
tachycardias in young patients. Familial history of tachycardias tended to be
more frequent in patients with negative study. Tachycardias associated with
dizziness /syncope or chest pain are generally not related to a reentrant tachy-
cardia but only to a sinus tachycardia.
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Impact of micro transoesophageal echocardiography for congenital
cardiac surgery in operating room and pediatric intensive care unit
Marianne Peyre (1), Philippe Acar (1), Sébastien Hascoet (1), Khaled
Hadeed (1), Gerald Chausseray (2), Sophie Breinig (3), Xavier Alacoque (2),
Lionel Berthomieux (3), Rose Fesseau (2), Marie-Odile Marcoux (3),
Romain Amadieu (1), Alexandre Cazavet (4), Bertrand Leobon (4)
(1) CHU Toulouse, Hôpital des enfants, Cardiologie pédiatrique, Toulouse,
France – (2) Anesthésie Réanimation, Toulouse, France – (3) Réanimation
Pédiatrique, Toulouse, France – (4) Chirurgie Cardiaque, Toulouse, France
Purpose: Transoesophageal echocardiography (TEE) impact on post-oper-
ative issue is is unknown and its application in operating room (OR) and pedi-
atric intensive care unit (PICU) debated. 
Aims: (1) To describe residual lesions by TEE in the immediate and
follow-up post-operative period. (2) To determine the feasibility of a new
micro-TEE probe dedicated in small infants. 
Methods: 196 patients were prospectively enrolled. From 2010 to 2012,
mini-multi pediatric TEE (4-7 MHz, tip-length 27mm, tip-width 10.6 mm)
was performed in 176 patients (median weight 15.1 kg [4.5-7]. From 2013,
micro TEE (3-8 MHz, tip-length 18.5 mm, tip-width 7.5 mm) was performed
in 20 patients (median weight 11.7 kg, [3.5-40]. Operated lesions were (1)
left-to-right shunt, (2) pulmonary obstruction with VSD, (3) left AV valve
regurgitation (LAVVR). Residual lesions were assessed by TEE in the OR and
by TTE at the last visit (mean follow-up 5 months after surgery). Lesions were
classified as severe (residual shunt (RS) > 5mm, maximal pulmonary gradient
(PG) > 50 mmHg, LAVVR grade 4) , as moderate (RS 2-5 mm, PG 35-
50 mmHg, LAVVR grade 2-3), as mild (RS <2mm, PG < 35 mmHg, LAVVR
grade < 2). Micro-TEE image quality was scored from 0 to 2. 
Results: 110 patients (56%) had none residual lesions in the OR. Signif-
icant lesions were observed in 6 patients (3%), all have had a redo surgery
(1 RS, 2 PG, 3 LAVVR). Moderate lesions were observed in 17 patients
(9%): 1 RS (stable), 9 PG (1 regression, 4 stable, 4 aggravated lesions:
3 awaiting for reoperation and 1 dilated by balloon), 7 stable LAVVR. Mild
lesions were observed in 63 patients (32%): 30 RS (24 regression, 3 stable,
3 moderate), 16 PG (4 regression, 4 stable, 4 moderate), 17 LAVVR (6 regres-
sion, 7 stable, 4 moderate). Image quality of micro TEE was scored 1 for 2D
and 2 for Doppler. In 3 patients on circulatory assistance, micro TEE could be
performed in PICU with good tolerance and acceptable quality. 
Conclusions: TEE is a tool (with others) to evaluate hemodynamic signi-
ficance of post-operative residual lesions. New microprobe offers possibility
to perform TEE in small infant in OR and in unstable patients with deficient
TTE in PICU.
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Systematic description of cardiac phenotype based on the anatomical
and clinical classification (ACC-CHD) in a DNA bank for congenital
heart disease
Daniela Laux (1), Fanny Bajolle (1), Virginie Salle (1), Stanilas Lyonnet (2),
Younes Boudjemline (1), Damien Bonnet (1)
(1) Hôpital Necker Enfants Malades, Cardiologie pédiatrique, Paris, France
– (2) Hôpital Necker Enfants-Malades, Génétique médicale, Paris, France
Background: DNA banks containing samples of patients with congenital
heart disease are being developed at international level. The accurate anatomic
description of the cardiac phenotype of such samples is a key feature for their
success. 
Objective and methods: to precisely describe the cardiac phenotype of the
available samples of the “CARREG” DNA bank, started in April 2009 in our
institution, based on the recently published clinical and anatomic classification
(ACC-CHD) and the International Pediatric and Congenital Cardiac Code
(IPCCC). Samples collected from 01.04.2009 to 31.10.2011 were classified ret-
rospectively based on medical records including surgical and imaging reports.
Samples collected from 01.11.2011 onwards were classified prospectively.
Results: Since creation of the DNA bank, 2364 blood samples have been
collected after informed consent of patients and their legal representatives.
They are stored in a dedicated space of the institution’s general DNA-bank.
Among them, there are 1299 patients’ samples and 1065 samples belonging to
parents or relatives. 416 triple samples (patient and both parents) have been
obtained. 158 samples come from families with at least two members affected
by congenital heart disease. 88 samples belong to patients without congenital
cardiac defects but with other severe cardiac pathologies. 652 patient samples
(50%) were coded retrospectively. Based on the ACC-CHD classification,
“CARREG” contains 658 samples (51%) belonging to the group 8 (anomalies
of the outflow tract). 152 samples (12%) were attributed to group 4 (anomalies
of the atrioventricular valve). The remaining samples were classified in group
1: 41 (3%), group 2: 22 (2%), group 3: 85 (7), group 5: 31 (2%), group 6: 62
(5%), group 7: 55 (4%), group 9: 95 (7%) and group 10: 9 (1%).
Perspectives: To make international comparison and data exchange easier,
cardiac phenotyping in “CARREG” relies on IPCCC and the newly developed
ACC-CHD. First cooperations with national and international research partner
are in progress. The development of a limited access website as communica-
tive platform for researchers will be one of the major goals in the near future.
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Long term outcome of the arterial switch for transposition of the
great arteries in Tunisian children. First experience in an emergent
country.
Marouane Boukhris, Kaouthar Hakim, Rafik Boussaada
CHU la Rabta, Département de cardiologie pédiatrique, Tunis, Tunisie
Introduction: After its introduction by Jatene and colleagues in 1975, the
Arterial Switch Operation (ASO) has become the surgical technique of choice
for correction of transposition of The Great Arteries (TGA) with or without
Ventricular Septal Defect (VSD). Although short- and mid-term results are
promising, data on long-term outcome are limited.
Objectives: Our study aimed to assess the long term results of ASO in
Tunisian children with TGA and to identify potential factors affecting these
results.
Methods: We studied 44 patients with ASO (mean age: 11.5±4.23 years,
73%-male, 50% TGA with VSD) followed at our department. The inclusion
criterion was at least 5 years follow-up. Complete clinical examination, stan-
dard and 24-hour Holter electrocardiogram, echocardiography and coronary
investigations were performed in all cases.
Results: Mean follow-up was 8.83 years (5-20 years). One patient died
(2.27%). Impaired left ventricular function was observed in 5 cases (11.36%).
Right ventricular outflow tract obstruction was noticed in 6 patients (13.63%)
requiring reintervention in 2 cases. Pulmonary regurgitation was frequent
(40.90%). Aortic regurgitation was observed in 20 patients (45.45%) but
appeared not to be progressive. Coronary lesions were found in 4 patients
(9.09%) requiring a coronary artery bypass graft in 1 case. Intramural coronary
artery course was the risk factor of late coronary arteries lesions (p=0.013).
Freedom from late reintervention was 84% at 15 years after ASO. Eight late
reinterventions were performed in 4 patients (9.09%) with a mean age of 10.43
years.
Conclusions: The TGA, including complex types, can be corrected with
good long-term outcomes by ASO. The association to a VSD was not consi-
dered to be a predictor of long-term complications except of aortic regurgita-
tion. Right ventricular outflow tract dysfunction was the main reason for late
reinterventions. Potential risk of myocardial ischemia requires regular appro-
priate follow up (figure next page).
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Peripheral vascular complications in patients with bicuspid aortic valve
Hélène Bouchery (1), Fabien Labombarda (1), Claire Méry (1), Arnaud
Pellissier (1), Eric Saloux (1), Pascale Maragnes (1), Paul Milliez (2)
(1) CHU Caen, Cardiologie, Caen, France – (2) CHU Côte de Nacre,
Cardiologie, Caen, France
Background: Bicuspid aortic valve (BAV) disease is the most common
congenital cardiac defect. It is generally assumed that BAV is associated with
vasculopathy. Although the most feared complication is aortic dissection, the
most frequent associated finding is dilatation of the proximal ascending aorta
secondary to abnormalities of the aortic media comparable to patients with
heritable connective tissue disorders such as Marfan's syndrome. No previous
study has looked for an association between BAV and peripheral vascular dis-
ease, although a possible relationship has been identified in case reports.
Methods: A retrospective single-center study identified a cohort of
176 patients with BAV. Peripheral vascular complications encountered in
connective tissue diseases, i.e. vascular dissection or aneurysm, were regis-
tered. We excluded aortic dissection.
Results: 8 patients (4.5%) presented a peripheral vascular complication:
6 patients presented spontaneous cervico-cephalic arteries dissections or intra-
cranial aneurysms (3.4%), 1 patient presented a spontaneous coronary artery
dissection (0.6%) and 1 patient presented a splenic artery aneurysm rupture
(0.6%). Interestingly, 1 patient presented a spontaneous uterine rupture (0.6%)
which typically occurs in vascular Ehler’s Danlos syndrome. Among these
patients, 5 patients had aortic dilatation (55,6%).
Conclusion: Patients with BAV are at risk to develop complications
encountered in heritable connective disorders, independent of whether the
aorta is dilated or not. 
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Isolated left ventricular non compaction: relationships between MRI
criteria for non compaction and clinical events
Delphine Marest 
Hôpital Guilaume et René Laennec, Cardiologie, Nantes, France
Isolated ventricular non compaction is a congenital cardiomyopathy, based
on an arrest of normal embryonic myocardium development and characterized
by the presence of a two- layered myocardial structure, with a compacted epi-
cardial band and a non-compacted endocardial layer of prominent trabecula-
tions. It is sometimes complicated by ventricular dysfunction and heart failure,
arrhythmias or thrombo-embolic events. The aim of our study was to look for
a potential relationship between MRI’s non compaction extension criteria and
these clinical events.
Between 2004 and 2013, we conducted at the University Medical Center
of Nantes a retrospective study reviewing MRI with diagnosis of non-compac-
tion. 125 patients presented MRI’s non compaction criteria, but 26 of them
had another associated cardiomyopathy. 99 patients fulfilled the diagnosis of
isolated ventricular non compaction and were included. LVEF, left ventricular
volumes, global LV mass, compacted LV mass, number of non-compacted
segments and non-compaction score were measured.
There were no statistical relationship between LVEF alteration and non-
compaction score (p=0.57) or number of non-compacted segments (p =0.97),
between stroke incidence and non-compaction score (p=0.22) or number of
non-compacted segments (p=0.96) and between ventricular arrhythmias and
non-compaction score (p=0.59) and number of non-compacted segments
(p=0.59). Conversely, we found a significant inverse relation between LVEF
and compacted mass (p<0.0001) and between stroke and compacted mass
(p=0.007). 
Our study didn’t show any association between MRI non compaction
extension criteria and clinical events such as LVEF dysfunction, stroke inci-
dence and ventricular arrhythmias. Conversely, we found a relationship
between compacted mass and LVEF dysfunction and stroke incidence. We can
conclude that isolated left ventricular non compaction is not only a disease of
the non-compacted part of the myocardium, but also reaches its compacted
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